- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pediatric Drugs and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pediatric Drugs and Vaccines size is estimated to be xx million in 2021 from USD 98250 million in 2020, with a change of XX% between 2020 and 2021. The global Pediatric Drugs and Vaccines market size is expected to grow at a CAGR of 8.7% for the next five years.
Market segmentation
Pediatric Drugs and Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market segment by Application can be divided into
Newborn
Infant
Child
The key market players for global Pediatric Drugs and Vaccines market are listed below:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pediatric Drugs and Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pediatric Drugs and Vaccines, with price, sales, revenue and global market share of Pediatric Drugs and Vaccines from 2019 to 2021.
Chapter 3, the Pediatric Drugs and Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Drugs and Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pediatric Drugs and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pediatric Drugs and Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Pediatric Drugs and Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pediatric Drugs and Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pediatric Drugs and Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Global Pediatric Drugs and Vaccines Market Size & Forecast
1.4.1 Global Pediatric Drugs and Vaccines Sales in Value (2016-2026))
1.4.2 Global Pediatric Drugs and Vaccines Sales in Volume (2016-2026)
1.4.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2026) & (USD/Kg)
1.5 Global Pediatric Drugs and Vaccines Production Capacity Analysis
1.5.1 Global Pediatric Drugs and Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Pediatric Drugs and Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pediatric Drugs and Vaccines Market Drivers
1.6.2 Pediatric Drugs and Vaccines Market Restraints
1.6.3 Pediatric Drugs and Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co., Inc. (USA)
2.1.1 Merck & Co., Inc. (USA) Details
2.1.2 Merck & Co., Inc. (USA) Major Business
2.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Abbott Laboratories (USA)
2.2.1 Abbott Laboratories (USA) Details
2.2.2 Abbott Laboratories (USA) Major Business
2.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product and Services
2.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Amgen, Inc. (USA)
2.3.1 Amgen, Inc. (USA) Details
2.3.2 Amgen, Inc. (USA) Major Business
2.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eli Lilly and Company (USA)
2.4.1 Eli Lilly and Company (USA) Details
2.4.2 Eli Lilly and Company (USA) Major Business
2.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product and Services
2.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 F. Hoffmann-La Roche Ltd (Switzerland)
2.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Details
2.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Major Business
2.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product and Services
2.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Genentech, Inc. (USA)
2.6.1 Genentech, Inc. (USA) Details
2.6.2 Genentech, Inc. (USA) Major Business
2.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 GlaxoSmithKline plc. (UK)
2.7.1 GlaxoSmithKline plc. (UK) Details
2.7.2 GlaxoSmithKline plc. (UK) Major Business
2.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product and Services
2.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Janssen Biologics B.V. (USA)
2.8.1 Janssen Biologics B.V. (USA) Details
2.8.2 Janssen Biologics B.V. (USA) Major Business
2.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product and Services
2.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Actelion Pharmaceuticals
2.9.1 Actelion Pharmaceuticals Details
2.9.2 Actelion Pharmaceuticals Major Business
2.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product and Services
2.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 AstraZeneca Plc. (UK)
2.10.1 AstraZeneca Plc. (UK) Details
2.10.2 AstraZeneca Plc. (UK) Major Business
2.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product and Services
2.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Boehringer Ingelheim GmbH (Germany)
2.11.1 Boehringer Ingelheim GmbH (Germany) Details
2.11.2 Boehringer Ingelheim GmbH (Germany) Major Business
2.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product and Services
2.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Bristol-Myers Squibb Company (USA)
2.12.1 Bristol-Myers Squibb Company (USA) Details
2.12.2 Bristol-Myers Squibb Company (USA) Major Business
2.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product and Services
2.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Allergan, Inc. (USA)
2.13.1 Allergan, Inc. (USA) Details
2.13.2 Allergan, Inc. (USA) Major Business
2.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Novartis AG (Switzerland)
2.14.1 Novartis AG (Switzerland) Details
2.14.2 Novartis AG (Switzerland) Major Business
2.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product and Services
2.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Novo Nordisk A/S (Denmark)
2.15.1 Novo Nordisk A/S (Denmark) Details
2.15.2 Novo Nordisk A/S (Denmark) Major Business
2.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product and Services
2.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Pfizer, Inc. (USA)
2.16.1 Pfizer, Inc. (USA) Details
2.16.2 Pfizer, Inc. (USA) Major Business
2.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Sanofi S.A (France)
2.17.1 Sanofi S.A (France) Details
2.17.2 Sanofi S.A (France) Major Business
2.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Product and Services
2.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Shionogi Inc. (USA)
2.18.1 Shionogi Inc. (USA) Details
2.18.2 Shionogi Inc. (USA) Major Business
2.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product and Services
2.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Takeda
2.19.1 Takeda Details
2.19.2 Takeda Major Business
2.19.3 Takeda Pediatric Drugs and Vaccines Product and Services
2.19.4 Takeda Pediatric Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pediatric Drugs and Vaccines Sales by Manufacturer
3.1 Global Pediatric Drugs and Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pediatric Drugs and Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pediatric Drugs and Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Pediatric Drugs and Vaccines Manufacturer Market Share
3.4.2 Top 6 Pediatric Drugs and Vaccines Manufacturer Market Share
3.5 Global Pediatric Drugs and Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pediatric Drugs and Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pediatric Drugs and Vaccines Market Size by Region
4.1.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Region (2016-2026)
4.2 North America Pediatric Drugs and Vaccines Revenue (2016-2026)
4.3 Europe Pediatric Drugs and Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Pediatric Drugs and Vaccines Revenue (2016-2026)
4.5 South America Pediatric Drugs and Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Pediatric Drugs and Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pediatric Drugs and Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Pediatric Drugs and Vaccines Revenue by Type (2016-2026)
5.3 Global Pediatric Drugs and Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pediatric Drugs and Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Pediatric Drugs and Vaccines Revenue by Application (2016-2026)
6.3 Global Pediatric Drugs and Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pediatric Drugs and Vaccines Sales by Type (2016-2026)
7.2 North America Pediatric Drugs and Vaccines Sales by Application (2016-2026)
7.3 North America Pediatric Drugs and Vaccines Market Size by Country
7.3.1 North America Pediatric Drugs and Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Pediatric Drugs and Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pediatric Drugs and Vaccines Sales by Type (2016-2026)
8.2 Europe Pediatric Drugs and Vaccines Sales by Application (2016-2026)
8.3 Europe Pediatric Drugs and Vaccines Market Size by Country
8.3.1 Europe Pediatric Drugs and Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pediatric Drugs and Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Pediatric Drugs and Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Pediatric Drugs and Vaccines Market Size by Region
9.3.1 Asia-Pacific Pediatric Drugs and Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pediatric Drugs and Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pediatric Drugs and Vaccines Sales by Type (2016-2026)
10.2 South America Pediatric Drugs and Vaccines Sales by Application (2016-2026)
10.3 South America Pediatric Drugs and Vaccines Market Size by Country
10.3.1 South America Pediatric Drugs and Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Pediatric Drugs and Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Pediatric Drugs and Vaccines Market Size by Country
11.3.1 Middle East & Africa Pediatric Drugs and Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pediatric Drugs and Vaccines Typical Distributors
12.3 Pediatric Drugs and Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Pediatric Drugs and Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pediatric Drugs and Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co., Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc. (USA) Major Business
Table 5. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 6. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Laboratories (USA) Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories (USA) Major Business
Table 9. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product and Services
Table 10. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Amgen, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 12. Amgen, Inc. (USA) Major Business
Table 13. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 14. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly and Company (USA) Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly and Company (USA) Major Business
Table 17. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product and Services
Table 18. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd (Switzerland) Major Business
Table 21. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product and Services
Table 22. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Genentech, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 24. Genentech, Inc. (USA) Major Business
Table 25. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 26. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GlaxoSmithKline plc. (UK) Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline plc. (UK) Major Business
Table 29. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product and Services
Table 30. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Janssen Biologics B.V. (USA) Basic Information, Manufacturing Base and Competitors
Table 32. Janssen Biologics B.V. (USA) Major Business
Table 33. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product and Services
Table 34. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Actelion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Actelion Pharmaceuticals Major Business
Table 37. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product and Services
Table 38. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. AstraZeneca Plc. (UK) Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Plc. (UK) Major Business
Table 41. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product and Services
Table 42. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim GmbH (Germany) Major Business
Table 45. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product and Services
Table 46. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Bristol-Myers Squibb Company (USA) Basic Information, Manufacturing Base and Competitors
Table 48. Bristol-Myers Squibb Company (USA) Major Business
Table 49. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product and Services
Table 50. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Allergan, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 52. Allergan, Inc. (USA) Major Business
Table 53. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 54. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 56. Novartis AG (Switzerland) Major Business
Table 57. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product and Services
Table 58. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Novo Nordisk A/S (Denmark) Basic Information, Manufacturing Base and Competitors
Table 60. Novo Nordisk A/S (Denmark) Major Business
Table 61. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product and Services
Table 62. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Pfizer, Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 64. Pfizer, Inc. (USA) Major Business
Table 65. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 66. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Sanofi S.A (France) Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi S.A (France) Major Business
Table 69. Sanofi S.A (France) Pediatric Drugs and Vaccines Product and Services
Table 70. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Shionogi Inc. (USA) Basic Information, Manufacturing Base and Competitors
Table 72. Shionogi Inc. (USA) Major Business
Table 73. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product and Services
Table 74. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Pediatric Drugs and Vaccines Product and Services
Table 78. Takeda Pediatric Drugs and Vaccines Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Pediatric Drugs and Vaccines Sales by Manufacturer (2019-2021e) & (Kg)
Table 80. Global Pediatric Drugs and Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Pediatric Drugs and Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Pediatric Drugs and Vaccines Production Capacity by Company, (Kg): 2020 VS 2021
Table 83. Head Office and Pediatric Drugs and Vaccines Production Site of Key Manufacturer
Table 84. Pediatric Drugs and Vaccines New Entrant and Capacity Expansion Plans
Table 85. Pediatric Drugs and Vaccines Mergers & Acquisitions in the Past Five Years
Table 86. Global Pediatric Drugs and Vaccines Sales by Region (2016-2021e) & (Kg)
Table 87. Global Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (Kg)
Table 88. Global Pediatric Drugs and Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 89. Global Pediatric Drugs and Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 90. Global Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 91. Global Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 92. Global Pediatric Drugs and Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 93. Global Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 94. Global Pediatric Drugs and Vaccines Price by Type (2016-2021e) & (USD/Kg)
Table 95. Global Pediatric Drugs and Vaccines Price by Type (2021-2026) & (USD/Kg)
Table 96. Global Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 97. Global Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 98. Global Pediatric Drugs and Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 99. Global Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 100. Global Pediatric Drugs and Vaccines Price by Application (2016-2021e) & (USD/Kg)
Table 101. Global Pediatric Drugs and Vaccines Price by Application (2021-2026) & (USD/Kg)
Table 102. North America Pediatric Drugs and Vaccines Sales by Country (2016-2021e) & (Kg)
Table 103. North America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (Kg)
Table 104. North America Pediatric Drugs and Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 105. North America Pediatric Drugs and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 106. North America Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 107. North America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 108. North America Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 109. North America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 110. Europe Pediatric Drugs and Vaccines Sales by Country (2016-2021e) & (Kg)
Table 111. Europe Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (Kg)
Table 112. Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 113. Europe Pediatric Drugs and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 114. Europe Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 115. Europe Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 116. Europe Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 117. Europe Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 118. Asia-Pacific Pediatric Drugs and Vaccines Sales by Region (2016-2021e) & (Kg)
Table 119. Asia-Pacific Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (Kg)
Table 120. Asia-Pacific Pediatric Drugs and Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 121. Asia-Pacific Pediatric Drugs and Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 123. Asia-Pacific Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 124. Asia-Pacific Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 125. Asia-Pacific Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 126. South America Pediatric Drugs and Vaccines Sales by Country (2016-2021e) & (Kg)
Table 127. South America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (Kg)
Table 128. South America Pediatric Drugs and Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 129. South America Pediatric Drugs and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 130. South America Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 131. South America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 132. South America Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 133. South America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 134. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2016-2021e) & (Kg)
Table 135. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (Kg)
Table 136. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 137. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2016-2021e) & (Kg)
Table 139. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (Kg)
Table 140. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2016-2021e) & (Kg)
Table 141. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (Kg)
Table 142. Direct Channel Pros & Cons
Table 143. Indirect Channel Pros & Cons
Table 144. Pediatric Drugs and Vaccines Typical Distributors
Table 145. Pediatric Drugs and Vaccines Typical Customers
List of Figures
Figure 1. Pediatric Drugs and Vaccines Picture
Figure 2. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2020
Figure 3. Diphtheria
Figure 4. Influenza
Figure 5. Hepatitis
Figure 6. Pneumococcal Diseases
Figure 7. Meningococcal Diseases
Figure 8. Mumps
Figure 9. Others
Figure 10. Global Pediatric Drugs and Vaccines Sales Market Share by Application in 2020
Figure 11. Newborn
Figure 12. Infant
Figure 13. Child
Figure 14. Global Pediatric Drugs and Vaccines Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 15. Global Pediatric Drugs and Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Pediatric Drugs and Vaccines Sales (2016-2026) & (Kg)
Figure 17. Global Pediatric Drugs and Vaccines Price by Type (2016-2026) & (USD/Kg)
Figure 18. Global Pediatric Drugs and Vaccines Production Capacity (2016-2026) & (Kg)
Figure 19. Global Pediatric Drugs and Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Pediatric Drugs and Vaccines Market Drivers
Figure 21. Pediatric Drugs and Vaccines Market Restraints
Figure 22. Pediatric Drugs and Vaccines Market Trends
Figure 23. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturer in 2020
Figure 24. Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturer in 2020
Figure 25. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Pediatric Drugs and Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Pediatric Drugs and Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2026)
Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2026)
Figure 30. North America Pediatric Drugs and Vaccines Revenue (2016-2026) & (USD Million)
Figure 31. Europe Pediatric Drugs and Vaccines Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Pediatric Drugs and Vaccines Revenue (2016-2026) & (USD Million)
Figure 33. South America Pediatric Drugs and Vaccines Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Pediatric Drugs and Vaccines Revenue (2016-2026) & (USD Million)
Figure 35. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2026)
Figure 36. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2026)
Figure 37. Global Pediatric Drugs and Vaccines Price by Type (2016-2026) & (USD/Kg)
Figure 38. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 39. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2026)
Figure 40. Global Pediatric Drugs and Vaccines Price by Application (2016-2026) & (USD/Kg)
Figure 41. North America Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2026)
Figure 42. North America Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 43. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2026)
Figure 44. North America Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2026)
Figure 45. United States Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2026)
Figure 49. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 50. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2026)
Figure 51. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2026)
Figure 52. Germany Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region (2016-2026)
Figure 61. China Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2026)
Figure 68. South America Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 69. South America Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2026)
Figure 70. South America Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Pediatric Drugs and Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
